Medication info
Simvazet Tablet 10/10

Simvazet Tablet 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Bioxon Pharmaceutical Co., Ltd.
Appearance
White to pale yellow, bilaterally convex rectangular tablet
Packaging
30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu * 3)
Approval status
Active

MFDS item code 201603858 · Approved 2016.06.24 · Insurance code 658203270

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia: The dosage range for this medication is 10/10 mg to 10/40 mg once daily. The generally recommended initial dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting this medication or adjusting the dose, check serum lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have been taking 10/80 mg of this medication for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia: The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. Dosage in patients with hepatic impairment: No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Impaired Liver Function under Precautions for Use). Dosage in patients with renal impairment and chronic kidney disease: No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60 mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60 mL/min/1.73㎡, administer 10/20 mg of this medication once daily in the evening. Higher doses of this medication should be administered to these patients with caution and close monitoring (see 5. General Precautions under Precautions for Use). Dosage in elderly patients: No dose adjustment is necessary in elderly patients. Concomitant use with other medications (see 6. Interactions under Precautions for Use) Administer this medication at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medication. Patients receiving this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medication.

Ingredients

Manufacturer
Bioxon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication primarily helps patients with hypercholesterolemia, such as primary hypercholesterolemia, lower total cholesterol and bad LDL cholesterol, and triglyceride levels, while increasing good HDL cholesterol levels. It is especially effective in patients with familial hypercholesterolemia when used in conjunction with dietary modifications. For patients with homozygous familial hypercholesterolemia, it is used as an adjunctive therapy when other treatments are insufficient or difficult. It is important to consider risk factors adequately while using this medication, and it should be used in combination with a diet that restricts saturated fats and cholesterol intake. Additionally, it should be administered after a thorough review of serum lipid levels and the causes of dyslipidemia, and, if necessary, other underlying cause treatments should be prioritized. Considering these points, this medication is used to improve cholesterol regulation and enhance vascular health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose of this medication should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medication is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia: The dosage range for this medication is 10/10 mg to 10/40 mg once daily. The generally recommended initial dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting this medication or adjusting the dose, check serum lipid levels after an interval of at least 4 weeks and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medication should be used only in patients who have been taking 10/80 mg of this medication for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia: The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily in the evening. This medication is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. Dosage in patients with hepatic impairment: No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Impaired Liver Function under Precautions for Use). Dosage in patients with renal impairment and chronic kidney disease: No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60 mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60 mL/min/1.73㎡, administer 10/20 mg of this medication once daily in the evening. Higher doses of this medication should be administered to these patients with caution and close monitoring (see 5. General Precautions under Precautions for Use). Dosage in elderly patients: No dose adjustment is necessary in elderly patients. Concomitant use with other medications (see 6. Interactions under Precautions for Use) Administer this medication at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving this medication concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medication. Patients receiving this medication concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medication.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis. The risk of these side effects may increase especially when taken in high doses or in combination with certain medications. Patients with hypersensitivity to the components of this medication or active liver disease, as well as women who are pregnant or nursing, should not take it. Additionally, patients taking strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, or danazol should also avoid this medication. Caution is advised for patients with severe myasthenia gravis or ocular myasthenia gravis, and if symptoms such as myalgia, tenderness, or muscle weakness appear during use, consult a physician immediately. Patients with liver dysfunction should also be monitored carefully, and treatment should be discontinued if liver function tests consistently show abnormalities. During the course of this medication, do not take other medications without consulting a physician, and when prescribed new medications, it is essential to inform the physician that this medication is being taken. Women who are planning to become pregnant or may be pregnant should consult a physician before taking this medication and must discontinue use immediately if pregnancy is confirmed. It is also safest for nursing women to discontinue breastfeeding while on this medication. Elderly patients, especially those over 65, may respond more sensitively to this medication, hence caution is needed while using it. Additionally, this medication may raise blood sugar levels, so patients at risk for diabetes should check their blood sugar regularly. In the event of overdose, there is no specific antidote, so symptomatic treatment should be received, and regular check-ups and monitoring are crucial to prevent and manage side effects.

Side effects

  • myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 102 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • lumbago
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • altered taste
  • extraocular movement disorder
  • facial partial paralysis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • insomnia
  • nightmares
  • cognitive impairment
  • interstitial lung disease
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • eye muscle paralysis
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated gamma-GT
  • elevated bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucus stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and humidity, so it must be stored in a tightly sealed container. Additionally, avoid storing it in extremely hot or cold places and store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White to pale yellow, bilaterally convex rectangular tablet

Package unit

30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu * 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.